Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.

NATerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

November 14, 2022

Study Completion Date

December 1, 2022

Conditions
Mitral Regurgitation
Interventions
DEVICE

HARPOON Beating Heart Mitral Valve Repair System (MVRS)

Repair of the chordae tendinae in the mitral valve.

Trial Locations (10)

4020

Kepler Universitätsklinikum GmbH, Linz

6020

Medizinische Universität Innsbruck, Universitätsklinik für Herzchirurgie, Innsbruck

13353

Deutsches Herzzentrum Berlin, Berlin

40225

Universitätsklinikum Düsseldorf, Düsseldorf

49214

Schüchtermann Klinik, Bad Rothenfelde

61231

Kerckhoff Klinik GmbH, Bad Nauheim

89070

Universitätsklinik Ulm, Ulm

97616

Rhön Klinikum Kardiochirurgie, Bad Neustadt an der Saale

3435 CM

St. Antonius Ziekenhuis, Nieuwegein

SW3 6NP

Guy's and St Thomas' NHS FOUNDATION TRUST, of Royal Brompton and Harefield Hospitals, London

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY